Urinary Biomarker Study With Sulindac and Difluoromethylornithine
Status:
Withdrawn
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of 2 drugs (sulindac and
Difluoromethylornithine (DFMO)) either alone or in combination on biomarkers found in urine.